H-group (homology)
223.3 a+b domain in beta-lactamase/transpeptidase-like proteins
Ligands and drugs
4,460
Member domains
3,158
with ligand contacts (≤ 4 Å)
70.8% of members
2,616
with DrugDomain annotations
58.7% of members
1,468
with a DrugBank compound
32.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 223.3 belongs to X-group 223 Profilin-like, which binds 8.8 ligand superclasses per 20 proteins, broader than 74% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08375 | CEF | (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid | 46 |
| DB03472 | MA4 | Cyclohexyl-Hexyl-Beta-D-Maltoside | 40 |
| DB02145 | 1BO | Butyl alcohol | 26 |
| DB03530 | CAZ | Acylated ceftazidime | 26 |
| DB03834 | TBE | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine | 22 |
| DB04035 | CB4 | Ceftazidime BATSI | 19 |
| DB00142 | GLU | Glutamic acid | 17 |
| DB04133 | CED | Degraded Cephaloridine | 13 |
| DB08551 | SM2 | 3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid | 13 |
| DB00145 | GLY | Glycine | 12 |
| DB00355 | AZR | Aztreonam | 12 |
| DB12107 | 4D6 | Vaborbactam | 11 |
| DB00513 | ACA | Aminocaproic acid | 10 |
| DB04360 | BZB | Benzo[B]Thiophene-2-Boronic Acid | 10 |
| DB00130 | GLN | L-Glutamine | 9 |
| DB03658 | AXL | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 8 |
| DB00139 | SIN | Succinic acid | 7 |
| DB00766 | J01 | Clavulanic acid | 7 |
| DB01896 | APB | M-Aminophenylboronic Acid | 7 |
| DB00120 | PHE | Phenylalanine | 6 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 401 |
| NXL | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide | 130 |
| NAmetal | SODIUM ION | 94 |
| GLN | GLUTAMINE | 57 |
| MER | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 52 |
| MGmetal | MAGNESIUM ION | 49 |
| CAmetal | CALCIUM ION | 46 |
| IM2 | (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 45 |
| ZNmetal | ZINC ION | 45 |
| CEF | CEFOTAXIME, C3' cleaved, open, bound form | 43 |
| MA4 | CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE | 40 |
| PNM | OPEN FORM - PENICILLIN G | 40 |
| Kmetal | POTASSIUM ION | 38 |
| CAZ | ACYLATED CEFTAZIDIME | 35 |
| 4J6 | (4R,5S)-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 34 |
| BR | BROMIDE ION | 34 |
| IOD | IODIDE ION | 33 |
| 9F2 | Ceftriaxone | 31 |
| CDmetal | CADMIUM ION | 31 |
| 1BO | 1-BUTANOL | 28 |